AB-BIOTICS S.A. (ABB) is a biotechnology company focused on the research and development of natural probiotic strains and related products, and is part of the Kaneka Group (since 1949). AB-BIOTICS has a leading private strain bank in the world, with 200+ global patents granted related to the efficacy of strains, and is constantly committed to discovering, identifying, researching, and clinically validating new probiotic strains and efficacy. At present, ABB's mature probiotic product solutions cover 9 functional areas such as gastrointestinal health, immune health, pediatric health, blood lipid and metabolic health, mental health, skin health, oral health and eye health, and can provide 16 mature probiotic solutions with complete clinical and patent endorsements and 21 commercial strains. Its probiotic solutions have also been nominated for the NutraIngredients Award and won the annual award several times. AB-BIOTICS sincerely cooperates with partners around the world to jointly develop the health application of probiotic products for different populations.